160 related articles for article (PubMed ID: 23520313)
21. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
22. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice.
Redente EF; Black BP; Backos DS; Bahadur AN; Humphries SM; Lynch DA; Tuder RM; Zemans RL; Riches DWH
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):669-676. PubMed ID: 33406369
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
[TBL] [Abstract][Full Text] [Related]
24. Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.
Lee HJ; Goo JM; Kim NR; Kim MA; Chung DH; Son KR; Kim HC; Lee CH; Park CM; Chun EJ; Im JG
Invest Radiol; 2008 Jun; 43(6):453-60. PubMed ID: 18496052
[TBL] [Abstract][Full Text] [Related]
25. [Effect of water-soluble C(60) fullerenes on pulmonary fibrosis induced by bleomycin in mice].
Dong R; Liu M; Huang XX; Liu Z; Jiang DY; Xiao HJ; Dai HP
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(22):1740-1744. PubMed ID: 28606286
[No Abstract] [Full Text] [Related]
26. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
He F; Zhou A; Feng S
PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
[TBL] [Abstract][Full Text] [Related]
27. Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis.
Li M; Krishnaveni MS; Li C; Zhou B; Xing Y; Banfalvi A; Li A; Lombardi V; Akbari O; Borok Z; Minoo P
J Clin Invest; 2011 Jan; 121(1):277-87. PubMed ID: 21135509
[TBL] [Abstract][Full Text] [Related]
28. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
[TBL] [Abstract][Full Text] [Related]
29. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
30. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography.
Cavanaugh D; Travis EL; Price RE; Gladish G; White RA; Wang M; Cody DD
Acad Radiol; 2006 Dec; 13(12):1505-12. PubMed ID: 17138119
[TBL] [Abstract][Full Text] [Related]
31. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
[TBL] [Abstract][Full Text] [Related]
32. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
33. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.
Fusco R; Siracusa R; D'Amico R; Cordaro M; Genovese T; Gugliandolo E; Peritore AF; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092214
[TBL] [Abstract][Full Text] [Related]
34. Pivotal role of micro-CT technology in setting up an optimized lung fibrosis mouse model for drug screening.
Khalajzeyqami Z; Grandi A; Ferrini E; Ravanetti F; Leo L; Mambrini M; Giardino L; Villetti G; Stellari FF
PLoS One; 2022; 17(6):e0270005. PubMed ID: 35704641
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of fibrosis in vitro and in vivo with SPARC siRNA.
Wang JC; Lai S; Guo X; Zhang X; de Crombrugghe B; Sonnylal S; Arnett FC; Zhou X
Arthritis Res Ther; 2010; 12(2):R60. PubMed ID: 20359365
[TBL] [Abstract][Full Text] [Related]
37. Disruption of Calcium Signaling in Fibroblasts and Attenuation of Bleomycin-Induced Fibrosis by Nifedipine.
Mukherjee S; Ayaub EA; Murphy J; Lu C; Kolb M; Ask K; Janssen LJ
Am J Respir Cell Mol Biol; 2015 Oct; 53(4):450-8. PubMed ID: 25664495
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
39. The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.
Liang C; Li X; Zhang L; Cui D; Quan X; Yang W
Exp Mol Pathol; 2015 Oct; 99(2):279-85. PubMed ID: 26216407
[TBL] [Abstract][Full Text] [Related]
40. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
